These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10843220)

  • 1. Activation of antibacterial prodrugs by peptide deformylase.
    Wei Y; Pei D
    Bioorg Med Chem Lett; 2000 May; 10(10):1073-6. PubMed ID: 10843220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antibacterial activity of peptide deformylase inhibitors.
    Huntington KM; Yi T; Wei Y; Pei D
    Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.
    Apfel C; Banner DW; Bur D; Dietz M; Hirata T; Hubschwerlen C; Locher H; Page MG; Pirson W; Rossé G; Specklin JL
    J Med Chem; 2000 Jun; 43(12):2324-31. PubMed ID: 10882358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
    Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
    J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
    Gupta MK; Mishra P; Prathipati P; Saxena AK
    Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
    Tsume Y; Hilfinger JM; Amidon GL
    Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct spectrophotometric assay for peptide deformylase.
    Guo XC; Ravi Rajagopalan PT; Pei D
    Anal Biochem; 1999 Sep; 273(2):298-304. PubMed ID: 10469501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric synthesis of BB-3497--a potent peptide deformylase inhibitor.
    Pratt LM; Beckett RP; Davies SJ; Launchbury SB; Miller A; Spavold ZM; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2585-8. PubMed ID: 11551755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.
    Margolis P; Hackbarth C; Lopez S; Maniar M; Wang W; Yuan Z; White R; Trias J
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2432-5. PubMed ID: 11502510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nonpeptidic inhibitors of peptide deformylase.
    Jayasekera MM; Kendall A; Shammas R; Dermyer M; Tomala M; Shapiro MA; Holler TP
    Arch Biochem Biophys; 2000 Sep; 381(2):313-6. PubMed ID: 11032420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of salinomycin conjugates with floxuridine.
    Huczyński A; Antoszczak M; Kleczewska N; Lewandowska M; Maj E; Stefańska J; Wietrzyk J; Janczak J; Celewicz L
    Eur J Med Chem; 2015 Mar; 93():33-41. PubMed ID: 25644674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.